Rapamycin
manufactures and commercializes sirolimus-based drugs for the treatment of dementia, cancer and autoimmune diseases... Read moreRapamycin
manufactures and commercializes sirolimus-based drugs for the treatment of dementia, cancer and autoimmune diseases... Read more
News
Feb 26, 2019
BioPortfolio
Rapamycin: Rapamycin Holdings Inc. Rebrands to Emtora Biosciences as New Leadership Focuses Company on Next Steps
Feb 26, 2019
The Business Journals: San Antonio
Rapamycin: Another San Antonio biotech changing its name and CEO
Nov 01, 2018
The Business Journals
Rapamycin: SA drug development company reaches major milestone
Sep 18, 2018
BioPortfolio
Rapamycin: Rapamycin Holdings Inc. Opens First Human Clinical Trial of its eRapaTM Compound Targeting Early Stage Prostate Cancer
May 09, 2018
Xconomy
Rapamycin: Rapamycin Holdings Plans Tests of Old Immune Drug in Prostate Cancer
Aug 07, 2017
BioSpace
Rapamycin: New CEO Takes Over Leads Funding Round With Plans for IND
Aug 07, 2017
Xconomy
Rapamycin: New Rapamycin CEO Hired to Handle Funding, FDA Inflection Points
Jul 11, 2017
The Business Journals
Rapamycin: Meet the new CEO tasked with taking SA drug developer's first product to market
Oct 05, 2015
SAN ANTONIO BUSINESS JOURNAL
Rapamycin: San Antonio biotech firm seeks major funding infusion
Jul 16, 2015
BIOSPACE
Rapamycin: <b>Rapamycin Holdings</b> Opens Investigational New Animal Drug Application With The FDA Center For Veterinary Medicine
Rapamycin Competitors
1
2
3
4
5
6
7
8
9
10